In accordance with the agreement, Mako will become a wholly owned subsidiary of Stryker.
Mako shareholders will receive $30 per share in cash when the merger officially goes through, according to the report.
More Articles on Supply Chain Transactions:
Valeant Pharmaceuticals Acquires Solta Medical
Myco Medical, Novation Enter Private-Label Contract
MediPurpose, EKF Diagnostics Sign Private Label Deal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
